PPIST16510
Protein Information
| Protein_Chain | A;B |
|---|---|
| Protein_Sequence | TTKGYKFNDEYRNLQWGLDLARLDETQDLINANRVSVTKICVIDSGIDYNHPDLRNNIDVNVKELHGRKGVDDDSNGVVDDVYGANFVSNSGDPMDDNYHGTHVSGIISAVGNNGIGIVGVDGHSKLVICKALDQHKLGRLGDMFKCIDYCISRQAHMISGSFSFDEYSNIFSASVEHLRSLGILFFVSASNCAHDKLSKPDIAKCDLAVNHRYPPILSKTHNNVIAVANLKRDLDESYSLSVNSFYSNIYCQLAAPGTNIYSTTPMNNYRKLNGTSMASPHVAAIASIVRSINPNLTYLQIVEILRNAIVKLPSLTERVSWGGYVDILRAVNLAIDSKAAPYIK |
Peptide Information
| Peptide_Chain | C;D |
|---|---|
| Peptide_Sequence | XITAXDE |
| Peptide_Length | 7 |
| Non-standard residues | Yes |
Interaction Information
| PDB_ID | 8COY |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 1.51 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | 3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived alpha-ketoamide inhibitor. |
|---|---|
| Release_Year | 2023 |
| PMID | 37428845 |
| DOI | 10.1107/S2059798323004710 |